Dhanvantri Jeevan Rekha Ltd.
Snapshot View

15.40 +0.40 ▲2.7%

16 August 2022, 04:01:00 PM
Volume: 983

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.djrl.org.in
Market Cap 6.31 Cr.
Enterprise Value(EV) 4.51 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 0.82 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 18.84 Trailing Twelve Months Ending 2022-06
Industry PE 47.92 Trailing Twelve Months Ending 2022-06
Book Value / Share 23.20 Trailing Twelve Months Ending 2022-06
Price to Book Value 0.66 Calculated using Price: 15.40
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 0.41 Cr. 4,098,400 Shares
FaceValue 10
Company Profile
Dhanvantri Jeevan Rekha, incorporated on June 11, 1993 is a multi speciality hospital providing reliable diagnostic and therapeutical services. We lay great emphasis on providing good nursing care and clean environment. Dhanvantri hospital has been on the fore front of providing state of art equipment and services in western UP since 1994.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+2.67%
1 Week
+14.07%
1 Month
+50.10%
3 Month
+13.65%
6 Month
-16.76%
1 Year
+45.01%
2 Year
+136.92%
5 Year
-62.16%
10 Year
+297.93%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 14.85 8.79 14.25 10.75 5.68 7.10 0.44 -2.51 -14.69
Return on Capital Employed (%) 17.32 14.04 21.14 16.71 11.79 7.91 1.97 -2.55 -16.37
Return on Assets (%) 11.06 6.83 10.82 7.95 3.77 4.46 0.30 -1.76 -10.42

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 6 7 8 9 10 11 11 10 9 10
Non Curr. Liab. 0 0 1 1 2 3 1 1 1 2
Curr. Liab. 2 2 2 2 4 3 3 3 3 2
Minority Int.
Equity & Liab. 8 8 11 13 16 16 15 15 13 14
Non Curr. Assets 5 5 7 8 13 13 13 12 11 11
Curr. Assets 2 3 4 4 3 3 3 3 2 4
Misc. Exp. not W/O
Total Assets 8 8 11 13 16 16 15 15 13 14

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 6 7 8 9 11 14 17 18 10 17
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 6 8 8 10 12 14 17 18 10 17
Total Expenditure -4 -6 -6 -8 -10 -12 -16 -18 -11 -16
PBIDT 2 2 2 2 2 2 1 1 -1 2
Interest 0 0 0 0 0 0 0 0 0
Depreciation -1 -1 0 0 0 -1 -1 -1 -1 -1
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 1 1 1 1 1 1 0 0 -1 0
Adjusted EPS 2 1 3 2 1 2 0 -1 -3 1

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 1 1 1 1 1 4 1 1 1 0
Cash Fr. Inv. -2 0 -1 -1 -1 -4 -1 0 0
Cash Fr. Finan. 0 0 0 0 1 0 -2 0 0
Net Change 0 0 0 0 0 0 0 -1 1 0
Cash & Cash Eqvt 0 1 0 0 1 1 1 0 1 1

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 19.77 19.77 19.77 19.77 19.77 19.77 19.77 19.77 19.77
Public 80.23 80.23 80.23 80.23 80.23 80.23 80.23 80.23 80.23
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 25 Jul 2022
Declaration In Respect Of Unmodified Opinion On Audited Financial<BR> Statements For The Financial Vear Ended 31St March 2022.<BR> Ref: Reg 33 Of SEBI (LODR) Regulation. 2015.
Pursuant to Reg.33(3) (d) of the SEBI (Listing Obligation and Disclosure Requirements)
Regulations 2015 and pursuant to the SEBI Circular CIR/CFD/CMD/56/2016 dated 26"
May 2016 we hereby declare and confirm that the Statutory Auditors of the Company
M/s.K.K. Jain & Co. Chartered Accountants have issued an Unmodified Audit Report on
Financial Statements of the Company for the year ended 31st March 2022.
Thu, 21 Jul 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (LODR) Regulations 2015 please find enclosed herewith the copy of the un-audited Financial Results for the quarter and year ended on 30th June 2022 published in Newspaper Jansatta (Hindi Edition) and Financial Express (English Edition) on 20.07.2022
Tue, 19 Jul 2022
Board Meeting Outcome for : Outcome Of The Board Meeting Held On 30Th June 2022 Pursuant To Regulation 30 Of SEBI (LODR) Regulations 2015

1. Approved the un-audited financial results for the quarter and year ended 30th June 2022. We attach herewith a copy of the reviewed un-audited financial results along with the limited review report.

We are arranging to publish these results in the newspaper as per Regulation 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015

2. Approved Appointment of M/s KPRS and Associates Firm Reg. 014851C as an Internal Auditor of the Company in accordance with section 138 of the Companies Act 2013

3. Approved the appointment of M/s Anju Bansal & Associates COP 17594 as a secretarial auditor of the company pursuant to section 204(1) of the Companies Act 2013 read with the Companies (Appointment and Remuneration Personnel) Rules 2014.

Technical Scans View Details >>

Fri, 12 Aug 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Opening at High Opening at High
Closing Above Previous High Closing Above Previous High

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,443.18 914.60 +0.1%
Divi's Laboratories Ltd. 99,072.87 3,732.00 +0.2%
Cipla Ltd. 83,487.41 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. 71,536.21 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. 62,537.70 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. 53,261.16 1,569.90 +2.0%
Piramal Enterprises Ltd. 45,983.34 1,926.70 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.42 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 31.92 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 33.44 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.91 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.76 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 66.33 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-06 24.47 1,926.70 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.38 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 3.87 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.53 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.52 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.31 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,926.70 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,926.70 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,926.70 +0.3%

FAQ's On Dhanvantri Jeevan Rekha Ltd.

Can I Buy DhanvantriJeevan Rek Shares now?

What is the Share Price of DhanvantriJeevan Rek?

What is the Relative Strength Index (RSI) Value of DhanvantriJeevan Rek?

What is the Market Capital (MCAP) of DhanvantriJeevan Rek?

What are the key metrics to analyse DhanvantriJeevan Rek?

What is the Price Performance of DhanvantriJeevan Rek?